29089869|t|MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy.
29089869|a|Synucleinopathies, neurodegenerative disorders with alpha-synuclein (alpha-syn) accumulation, are the second leading cause of neurodegeneration in the elderly, however no effective disease-modifying alternatives exist for these diseases. Multiple system atrophy (MSA) is a fatal synucleinopathy characterized by the accumulation of toxic aggregates of alpha-syn within oligodendroglial cells, leading to demyelination and neurodegeneration, and the reduction of this accumulation might halt the fast progression of MSA. In this sense, the involvement of microRNAs (miRNAs) in synucleinopathies is yet poorly understood, and the potential of manipulating miRNA levels as a therapeutic tool is underexplored. In this study, we analyzed the levels of miRNAs that regulate the expression of autophagy genes in MSA cases, and investigated the mechanistic correlates of miRNA dysregulation in in vitro models of synucleinopathy. We found that microRNA-101 (miR-101) was significantly increased in the striatum of MSA patients, together with a reduction in the expression of its predicted target gene RAB5A. Overexpression of miR-101 in oligodendroglial cell cultures resulted in a significant increase in alpha-syn accumulation, along with autophagy deficits. Opposite results were observed upon expression of an antisense construct targeting miR-101. Stereotaxic delivery of a lentiviral construct expressing anti-miR-101 into the striatum of the MBP-alpha-syn transgenic (tg) mouse model of MSA resulted in reduced oligodendroglial alpha-syn accumulation and improved autophagy. These results suggest that miRNA dysregulation contributes to MSA pathology, with miR-101 alterations potentially mediating autophagy impairments. Therefore, therapies targeting miR-101 may represent promising approaches for MSA and related neuropathologies with autophagy dysfunction.
29089869	54	69	Alpha-Synuclein	Gene	20617
29089869	86	109	Multiple System Atrophy	Disease	MESH:D019578
29089869	111	128	Synucleinopathies	Disease	MESH:D000080874
29089869	130	157	neurodegenerative disorders	Disease	MESH:D019636
29089869	163	178	alpha-synuclein	Gene	6622
29089869	180	189	alpha-syn	Gene	6622
29089869	237	254	neurodegeneration	Disease	MESH:D019636
29089869	349	372	Multiple system atrophy	Disease	MESH:D019578
29089869	374	377	MSA	Disease	MESH:D019578
29089869	390	405	synucleinopathy	Disease	MESH:D000080874
29089869	463	472	alpha-syn	Gene	6622
29089869	515	528	demyelination	Disease	MESH:D003711
29089869	533	550	neurodegeneration	Disease	MESH:D019636
29089869	626	629	MSA	Disease	MESH:D019578
29089869	687	704	synucleinopathies	Disease	MESH:D000080874
29089869	917	920	MSA	Disease	MESH:D019578
29089869	1017	1032	synucleinopathy	Disease	MESH:D000080874
29089869	1062	1069	miR-101	Gene	387143
29089869	1118	1121	MSA	Disease	MESH:D019578
29089869	1122	1130	patients	Species	9606
29089869	1205	1211	RAB5A.	Gene	5868
29089869	1230	1237	miR-101	Gene	387143
29089869	1310	1319	alpha-syn	Gene	20617
29089869	1448	1455	miR-101	Gene	387143
29089869	1520	1527	miR-101	Gene	387143
29089869	1553	1556	MBP	Gene	17196
29089869	1557	1566	alpha-syn	Gene	20617
29089869	1583	1588	mouse	Species	10090
29089869	1598	1601	MSA	Disease	MESH:D019578
29089869	1639	1648	alpha-syn	Gene	20617
29089869	1748	1751	MSA	Disease	MESH:D019578
29089869	1768	1775	miR-101	Gene	387143
29089869	1864	1871	miR-101	Gene	387143
29089869	1911	1914	MSA	Disease	MESH:D019578
29089869	Association	MESH:D019636	6622
29089869	Association	MESH:D019578	20617
29089869	Positive_Correlation	MESH:D019578	387143
29089869	Association	MESH:D003711	6622
29089869	Association	MESH:D019578	6622
29089869	Positive_Correlation	20617	387143
29089869	Association	MESH:D000080874	6622

